Related Stories
FDA Panel Recommends Ban on Nonprescription Asthma Inhalers
Key Excerpts from Article on Website of ABC/Associated Press
Posted: November 11th, 2006
http://abcnews.go.com/Health/wireStory?id=1537095
Millions of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves because they contain propellants that harm the ozone layer. An advisory panel voted 11-7 Tuesday to recommend that the Food and Drug Administration [FDA] remove the "essential use" status that Primatene Mist and other similar nonprescription inhalers require to be sold, spokeswoman Laura Alvey said. Final revocation of that status would mean a de facto ban on their sale. Wyeth Consumer Healthcare estimates that 3 million Americans use Primatene Mist for mild or intermittent cases of asthma. About two-thirds also use a prescription inhaler but rely on Primatene as a backup. Another 700,000 use the inhalers because they don't have a prescription or lack health insurance.
Note: This is an excellent example of the FDA and industry colluding to give drug companies big profits. Are these inhalers being banned because they harm the ozone or because they are generics which decrease sales of the big drug companies? For lots more, see the revealing article of the prestigious Journal of New England Medicine on drug company control of FDA and congress: http://www.WantToKnow.info/healthcoverup
Related Stories
Latest News
Key News Articles from Years Past
